Known hypersensitivity to egg or soy protein or to any of the ingredients/excipient of Kabiven/Kabiven Peripheral.
Severe hyperlipemia. Severe liver insufficiency. Severe blood coagulation disorders. Inborn errors of amino acid metabolism. Severe renal insufficiency without access to hemofiltration or dialysis. Acute shock. Hyperglycemia, which requires >6 units insulin/hr. Pathologically elevated serum levels of any of the included electrolytes.
General Contraindications to Infusion Therapy: Acute pulmonary edema, hyperhydration, decompensated cardiac insufficiency and hypotonic dehydration. Hemophagocytotic syndrome. Unstable conditions (eg, severe post-traumatic conditions, uncompensated diabetes, acute myocardial infarction, metabolic acidosis, severe sepsis and hyperosmolar coma).
Infants and children <2 years.